PMID- 23225136 OWN - NLM STAT- MEDLINE DCOM- 20130528 LR - 20220331 IS - 1573-2568 (Electronic) IS - 0163-2116 (Linking) VI - 58 IP - 4 DP - 2013 Apr TI - Factors predictive of adverse events following endoscopic papillary large balloon dilation: results from a multicenter series. PG - 1100-9 LID - 10.1007/s10620-012-2494-8 [doi] AB - BACKGROUND: Lack of established guidelines for endoscopic papillary large balloon dilation (EPLBD) may be a reason for aversion of its use in removal of large common bile duct (CBD) stones. AIMS: We sought to identify factors predictive of adverse events (AEs) following EPLBD. METHODS: This multicenter retrospective study investigated 946 consecutive patients who underwent attempted removal of CBD stones >/=10 mm in size using EPLBD (balloon size 12-20 mm) with or without endoscopic sphincterotomy (EST) at 12 academic medical centers in Korea and Japan. RESULTS: Ninety-five (10.0 %) patients exhibited AEs including bleeding in 56, pancreatitis in 24, perforation in nine, and cholangitis in six; 90 (94.7 %) of these were classified as mild or moderate in severity. There were four deaths, three as a result of perforation and one due to delayed massive bleeding. Causative factors identified in fatal cases were full-EST and continued balloon inflation despite a persistent waist seen fluoroscopically. Multivariate analyses showed that cirrhosis (OR 8.03, p = 0.003), length of EST (full-EST: OR 6.22, p < 0.001) and stone size (>/=16 mm: OR 4.00, p < 0.001) were associated with increased bleeding, and distal CBD stricture (OR 17.08, p < 0.001) was an independent predictor for perforation. On the other hand, balloon size was associated with deceased pancreatitis (>/=14 mm: OR 0.27, p = 0.015). CONCLUSIONS: EPLBD appears to be a safe and effective therapeutic approach for retrieval of large stones in patients without distal CBD strictures and when performed without full-EST. FAU - Park, Soo Jung AU - Park SJ AD - Division of Gastroenterology, Department of Internal Medicine, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonjuro Gangnam-gu, Seoul 135-720, Korea. FAU - Kim, Jin Hong AU - Kim JH FAU - Hwang, Jae Chul AU - Hwang JC FAU - Kim, Ho Gak AU - Kim HG FAU - Lee, Don Haeng AU - Lee DH FAU - Jeong, Seok AU - Jeong S FAU - Cha, Sang-Woo AU - Cha SW FAU - Cho, Young Deok AU - Cho YD FAU - Kim, Hong Ja AU - Kim HJ FAU - Kim, Jong Hyeok AU - Kim JH FAU - Moon, Jong Ho AU - Moon JH FAU - Park, Sang-Heum AU - Park SH FAU - Itoi, Takao AU - Itoi T FAU - Isayama, Hiroyuki AU - Isayama H FAU - Kogure, Hirofumi AU - Kogure H FAU - Lee, Se Joon AU - Lee SJ FAU - Jung, Kyo Tae AU - Jung KT FAU - Lee, Hye Sun AU - Lee HS FAU - Baron, Todd H AU - Baron TH FAU - Lee, Dong Ki AU - Lee DK LA - eng PT - Case Reports PT - Journal Article PT - Multicenter Study DEP - 20121208 PL - United States TA - Dig Dis Sci JT - Digestive diseases and sciences JID - 7902782 SB - IM CIN - Dig Dis Sci. 2013 Apr;58(4):894-6. PMID: 23456501 CIN - Dig Dis Sci. 2013 May;58(5):1438. PMID: 23504351 CIN - Dig Dis Sci. 2013 Aug;58(8):2427-8. PMID: 23673727 CIN - Dig Dis Sci. 2013 Aug;58(8):2426-7. PMID: 23812860 CIN - Dig Dis Sci. 2013 May;58(5):1438-9. PMID: 23841148 MH - Adult MH - Aged MH - Aged, 80 and over MH - Cholangiopancreatography, Endoscopic Retrograde/*adverse effects/mortality MH - Fatal Outcome MH - Female MH - Gallstones/*surgery MH - Humans MH - Male MH - Middle Aged MH - Republic of Korea/epidemiology MH - Retrospective Studies MH - Treatment Outcome MH - Young Adult EDAT- 2012/12/12 06:00 MHDA- 2013/05/29 06:00 CRDT- 2012/12/11 06:00 PHST- 2012/07/19 00:00 [received] PHST- 2012/11/11 00:00 [accepted] PHST- 2012/12/11 06:00 [entrez] PHST- 2012/12/12 06:00 [pubmed] PHST- 2013/05/29 06:00 [medline] AID - 10.1007/s10620-012-2494-8 [doi] PST - ppublish SO - Dig Dis Sci. 2013 Apr;58(4):1100-9. doi: 10.1007/s10620-012-2494-8. Epub 2012 Dec 8.